SOLITARY OSSEOUS PLASMACYTOMA

Clinical trials for SOLITARY OSSEOUS PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new SOLITARY OSSEOUS PLASMACYTOMA trials appear

Sign up with your email to follow new studies for SOLITARY OSSEOUS PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Could a drug cocktail halt bone Cancer's spread after radiation?

Disease control Terminated

This study tests whether adding a three-drug combination (ixazomib, lenalidomide, and dexamethasone) to zoledronic acid after radiation therapy can prevent solitary plasmacytoma of bone from turning into multiple myeloma. Participants receive either the drug combo plus zoledronic…

Matched conditions: SOLITARY OSSEOUS PLASMACYTOMA

Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

SOLITARY OSSEOUS PLASMACYTOMA

Get alerted when new SOLITARY OSSEOUS PLASMACYTOMA trials appear

Could a drug cocktail halt bone Cancer's spread after radiation?